Airway Inflammation Research Group

The Airway Inflammation Research Group (AIRG) at the University of Calgary is part of the Snyder Institute for Chronic Diseases and is involved in the study of a number of chronic lung diseases, including asthma, COPD, cystic fibrosis, interstitial pulmonary fibrosis, pneumonia and tuberculosis. Current therapies for a many of these diseases are less than ideal. The AIRG is well positioned to study these complex diseases from a number of different perspectives, including studies of inflammatory mechanisms, host defense, tissue remodeling and cell biology, and can test pharmacological interventions in both pre-clinical and clinical settings. This research is conducted in laboratories in the state-of-the-art Health Research Innovation Center and in a unique, dedicated Clinical Research Suite located in adjacent the Precision Health Building. the group is made up of basic and clinician scientists who are well recognized internationally in their areas of expertise. The collaborative atmosphere within the AIRG leads to a team effort to elucidate underlying disease mechanisms and to finding better therapeutic agents to treat these major diseases.